-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Reviewing Arrayit (OTCMKTS:ARYC) & Cue Health (NASDAQ:HLTH)
Reviewing Arrayit (OTCMKTS:ARYC) & Cue Health (NASDAQ:HLTH)
Arrayit (OTCMKTS:ARYC – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.
Insider and Institutional Ownership
44.6% of Cue Health shares are held by institutional investors. 58.0% of Arrayit shares are held by insiders. Comparatively, 29.4% of Cue Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Get Arrayit alerts:Volatility & Risk
Arrayit has a beta of -0.48, meaning that its stock price is 148% less volatile than the S&P 500. Comparatively, Cue Health has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and price targets for Arrayit and Cue Health, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Arrayit | 0 | 0 | 0 | 0 | N/A |
Cue Health | 0 | 1 | 3 | 0 | 2.75 |
Cue Health has a consensus target price of $7.00, suggesting a potential upside of 248.26%.
Earnings and Valuation
This table compares Arrayit and Cue Health's revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Arrayit | N/A | N/A | N/A | N/A | N/A |
Cue Health | $522.06 million | 0.58 | $86.42 million | ($0.88) | -2.28 |
Cue Health has higher revenue and earnings than Arrayit.
Profitability
This table compares Arrayit and Cue Health's net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Arrayit | N/A | N/A | N/A |
Cue Health | -24.25% | -12.29% | -8.93% |
About Arrayit
(Get Rating)
Arrayit Corp. engages in developing, manufacturing and marketing life science tools and integrated systems for the analysis of genetic variation, biological function and diagnostics. Its products include microarrayers, Microarray Scanners, DNA Microarrays, Protein Microarrays, Microarray Printing, Microarray Substrate Slides, Microarray Instrument, Amplification & Labeling, purification kits, Microarray Tools, buffers and solutions, microarray Cleanrooms, Books & software, CGH Microarrays and Microarray Platforms. The company provides tools and services to genomic research centres, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies. Arrayit was founded by Todd J. Martinsky in November 1999 and is headquartered in Sunnyvale, CA.
About Cue Health
(Get Rating)
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Receive News & Ratings for Arrayit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrayit and related companies with MarketBeat.com's FREE daily email newsletter.
Arrayit (OTCMKTS:ARYC – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.
阿拉伊特(OTCMKTS:ARYC-獲得評級)和提示健康(納斯達克:HLTH-獲得評級)都是醫療公司,但哪個是優越的股票?我們將根據兩家公司的風險,分析師建議,股息,機構所有權,估值,收益和盈利能力對比兩家公司。
Insider and Institutional Ownership
內幕和機構所有權
44.6% of Cue Health shares are held by institutional investors. 58.0% of Arrayit shares are held by insiders. Comparatively, 29.4% of Cue Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
44.6% 的 Cue Health 股份由機構投資者持有。58.0% 的安瑞特股份由內部人士持有。相比之下,29.4% 的 Cue 健康股份由內部人士持有。強大的機構所有權表明,對沖基金,捐贈基金和大型資金經理認為股票將在長期內優於市場。
Volatility & Risk
波動性和風險
Arrayit has a beta of -0.48, meaning that its stock price is 148% less volatile than the S&P 500. Comparatively, Cue Health has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500.
阿瑞特的測試值為 -0.48,這意味著其股票價格的波動性比標普 500 低 148%。相比之下,提示健康的測試值為 1.62,這意味著其股票價格比標普 500 高出 62% 的波動性。
Analyst Ratings
分析師評級
This is a summary of current ratings and price targets for Arrayit and Cue Health, as reported by MarketBeat.
這是 Arrayit 和提示健康當前評級和價格目標的摘要,根據 MarketBeat 的報告。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Arrayit | 0 | 0 | 0 | 0 | N/A |
Cue Health | 0 | 1 | 3 | 0 | 2.75 |
銷售評級 | 保留評分 | 購買評級 | 強大的買入評級 | 評級分數 | |
陣列 | 0 | 0 | 0 | 0 | N/A |
提示健康 | 0 | 1 | 3 | 0 | 2.75 |
Cue Health has a consensus target price of $7.00, suggesting a potential upside of 248.26%.
提示健康的共識目標價格為 7.00 美元,表明潛在的上行空間為 248.26%。
Earnings and Valuation
收益及估值
This table compares Arrayit and Cue Health's revenue, earnings per share and valuation.
此表格比較 Arrayit 和 Cue Health 的收入,每股收益和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Arrayit | N/A | N/A | N/A | N/A | N/A |
Cue Health | $522.06 million | 0.58 | $86.42 million | ($0.88) | -2.28 |
總收入 | 價格/銷售比率 | 淨收入 | 每股盈利 | 市盈比率 | |
陣列 | N/A | N/A | N/A | N/A | N/A |
提示健康 | 五億二百二十六萬元 | 0.58 | 八千六百四十二萬元 | (港幣 88 元) | -2.28 |
Cue Health has higher revenue and earnings than Arrayit.
提示健康比 Arrayit 具有更高的收入和收益。
Profitability
盈利
This table compares Arrayit and Cue Health's net margins, return on equity and return on assets.
此表格比較了 Arrayit 和 Cue Health 的淨利潤率,權益回報率和資產回報率。
Net Margins | Return on Equity | Return on Assets | |
Arrayit | N/A | N/A | N/A |
Cue Health | -24.25% | -12.29% | -8.93% |
淨利潤 | 權益回報率 | 資產回報率 | |
陣列 | N/A | N/A | N/A |
提示健康 | -24.25% | -12.29% | -8.93% |
About Arrayit
關於亞瑞特
(Get Rating)
(取得評分)
Arrayit Corp. engages in developing, manufacturing and marketing life science tools and integrated systems for the analysis of genetic variation, biological function and diagnostics. Its products include microarrayers, Microarray Scanners, DNA Microarrays, Protein Microarrays, Microarray Printing, Microarray Substrate Slides, Microarray Instrument, Amplification & Labeling, purification kits, Microarray Tools, buffers and solutions, microarray Cleanrooms, Books & software, CGH Microarrays and Microarray Platforms. The company provides tools and services to genomic research centres, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies. Arrayit was founded by Todd J. Martinsky in November 1999 and is headquartered in Sunnyvale, CA.
Arayit Corp. 從事開發、製造和行銷生命科學工具和整合系統,用於遺傳變異、生物功能和診斷的分析。其產品包括微陣列、微陣列掃描器、DNA 微陣列、蛋白質微陣列、微陣列印、微陣列基板滑軌、微陣列儀器、放大和標籤、淨化套件、微陣列工具、緩衝區和解決方案、微陣列潔淨室、書籍和軟體、CGH 微陣列和微陣列平台。該公司為基因組研究中心,製藥公司,學術機構,臨床研究組織,政府機構和生物技術公司提供工具和服務。阿拉伊特由托德 ·J· 馬丁斯基於 1999 年 11 月成立,總部位於加利福尼亞州桑尼韋爾。
About Cue Health
關於提示健康
(Get Rating)
(取得評分)
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Cue Health Inc. 是一家醫療保健技術公司,為個人,企業,醫療保健提供者和付款人以及公共衛生機構設計和開發診斷測試的診斷平台。該公司提供 Cue Integration Care 平台,包括硬件和軟件組件,例如 Cue Health 監控系統,包括 Cue Reader,便攜式和可重複使用的閱讀器,Cue Cue Care,一個單次使用的 test 盒和 Cue Ware,一個帶有基於雲的數據和分析功能的解決方案;Cue 虛擬護理交付應用程序,其中包括 Cue Health App 和 Cue 企業儀表板;具有基於雲的數據和分析功能的解決方案;Cue 虛擬護理交付應用程序,其中包括 Cue Health App 和 Cue 企業儀表板;具有基於雲的數據應用程式和感應器。它還為提示健康監測系統提供 COVID-19 測試套件該公司以前稱為 Cue Inc,並於 2017 年 12 月更名為 Cue Health 公司。Cue Health 股份有限公司成立於 2010 年,總部位於加利福尼亞州聖地牙哥。
Receive News & Ratings for Arrayit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrayit and related companies with MarketBeat.com's FREE daily email newsletter.
接收阿瑞特每日新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Arrayit 及相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧